Literature DB >> 4451813

The effects of acutely administered analgesics on the turnover of noradrenaline and dopamine in various regions of the rat brain.

M F Sugrue.   

Abstract

1 Noradrenaline and dopamine turnover rates were determined following blockade of synthesis by alpha-methyl-p-tyrosine. Morphine, pentazocine and methadone had no effect on steady state levels or on turnover of noradrenaline in whole brain and in the hypothalamus. Although morphine was without action on medulla-pons noradrenaline steady state levels, a drug-induced increase in turnover rate was observed which was antagonized by pretreatment with naloxone (5 mg/kg). Pentazocine and methadone failed to alter either the steady state level of noradrenaline in the medulla-pons or its turnover rate.2 Morphine accelerated the decline in striatal alpha-methyl-m-tyramine levels following subcutaneous injection of alpha-methyl-m-tyrosine 18 h previously.3 All three drugs increased the turnover of dopamine in whole brain and corpus striatum although the striatal effect was prevented by naloxone pretreatment. The minimum doses of morphine, pentazocine and methadone required to elicit a significant effect on striatal dopamine turnover were 10 mg/kg, 30 mg/kg and 10 mg/kg respectively.4 The possibility of a dopaminergic involvement in the antinociceptive effect of analgesics is discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4451813      PMCID: PMC1776860          DOI: 10.1111/j.1476-5381.1974.tb09696.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  On the role of a central adrenergic mechanism in morphine analgesic action.

Authors:  Y P Vedernikov; I I Afrikanov
Journal:  J Pharm Pharmacol       Date:  1969-12       Impact factor: 3.765

2.  Effects of morphine intoxication on brain catecholamine neurons.

Authors:  L M Gunne; J Jonsson; K Fuxe
Journal:  Eur J Pharmacol       Date:  1969-03       Impact factor: 4.432

3.  The fluorometric assay of catecholamines and related compounds: improvements and extensions to the hydroxyindole technique.

Authors:  R Laverty; K M Taylor
Journal:  Anal Biochem       Date:  1968-02       Impact factor: 3.365

4.  Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor.

Authors:  S S Tenen
Journal:  Psychopharmacologia       Date:  1968

5.  Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain.

Authors:  H Nybäck; G Sedvall
Journal:  J Pharmacol Exp Ther       Date:  1968-08       Impact factor: 4.030

6.  Catecholamine biosynthesis in brains of rats treated with morphine.

Authors:  D H Clouet; M Ratner
Journal:  Science       Date:  1970-05-15       Impact factor: 47.728

7.  A study of the role of noradrenaline in behavioral changes produced in the rat by psychotomimetic drugs.

Authors:  M F Sugrue
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

8.  The influence of monoamine oxidase inhibition on catecholamine synthesis.

Authors:  N H Neff; E Costa
Journal:  Life Sci       Date:  1966-05       Impact factor: 5.037

9.  Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines.

Authors:  B B Brodie; E Costa; A Dlabac; N H Neff; H H Smookler
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

10.  Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain.

Authors:  J Glowinski; L L Iversen
Journal:  J Neurochem       Date:  1966-08       Impact factor: 5.372

View more
  11 in total

1.  Specific opioid-amphetamine interactions in the caudate putamen.

Authors:  S K Woo; R J Hitzemann; H H Loh
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Effect of apomorphine on the antinociceptive activity of morphine.

Authors:  Z Dunai-Kovács; J I Székely
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

3.  Dexclamol: effects on catecholamine metabolism and demonstration of stereochemical specificity of antagonism of central adrenergic receptors.

Authors:  T A Pugsley; W Lippmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-11       Impact factor: 3.000

4.  Effect of morphine on dopaminergic neurons in the rat basal forebrain and striatum.

Authors:  P Moleman; J Bruinvels
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

5.  The effect of morphine on 5-hydroxytryptamine synthesis and metabolism in the striatum, and several discrete hypothalamic regions of the rat brain.

Authors:  C A Johnston; K E Moore
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

6.  Morphine dependence and dopaminergic activity: tests of circling responses in rats with unilateral nigral lesions.

Authors:  J V Halliwell; R Kumar
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

7.  Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.

Authors:  S Kaakkola; L Ahtee
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

8.  Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.

Authors:  L M Attila; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

9.  Acceleration of cerebral noradrenaline turnover after morphine withdrawal and its retardation by acute morphine administration in rats.

Authors:  L M Attila; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

10.  The effects of acute and chronic administration of morphine on the turnover of brain and adrenal catecholamines in rats.

Authors:  C Guaza; A Torrellas; S Borrell; J Borrell
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.